北京大学学报(医学版) ›› 2022, Vol. 54 ›› Issue (2): 278-282. doi: 10.19723/j.issn.1671-167X.2022.02.013

• 论著 • 上一篇    下一篇

类风湿关节炎合并纤维肌痛简易分类标准的临床验证

高超,陈立红(),王莉,姚鸿,黄晓玮,贾语博,刘田()   

  1. 北京大学人民医院风湿免疫科,北京 100044
  • 收稿日期:2020-07-31 出版日期:2022-04-18 发布日期:2022-04-13
  • 通讯作者: 陈立红,刘田 E-mail:13901007280@163.com;mikle317@163.com

Validation of the Pollard’s classification criteria (2010) for rheumatoid arthritis patients with fibromyalgia

GAO Chao,CHEN Li-hong(),WANG Li,YAO Hong,HUANG Xiao-wei,JIA Yu-bo,LIU Tian()   

  1. Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China
  • Received:2020-07-31 Online:2022-04-18 Published:2022-04-13
  • Contact: Li-hong CHEN,Tian LIU E-mail:13901007280@163.com;mikle317@163.com

RICH HTML

  

摘要:

目的: 验证类风湿关节炎(rheumatoid arthritis,RA)纤维肌痛(fibromyalgia,FM)简易分类标准(Pollard标准)在中国RA合并FM患者中诊断的敏感度和特异度,评估RA合并FM的临床特点。方法: 选择2018年12月—2019年6月在北京大学人民医院风湿免疫科门诊就诊的RA患者的病例资料进行回顾性分析,共入选病例202例,按照1990年美国风湿病学会(American College of Rheumatolgy, ACR)的FM分类标准诊断为FM的42例,将入组患者分为RA合并FM组(RA-FM组)42例和单纯RA组(RA组)160例。结果: 两组患者在一般人口学方面差异无统计学意义(P>0.05)。Pollard标准的敏感度为95.2%,特异度为52.6%。伴有FM的RA患者(RA-FM组)DAS28评分(5.95 vs. 4.38, P=0.011)较不伴FM的患者高,疼痛关节数(tender joint counts,TJC)(16.5 vs. 4.5, P<0.01)更多。RA-FM组患者功能状态HAQ评分(1.24 vs. 0.66, P<0.001)及生活质量SF36评分(28.63 vs. 58.22,P<0.001)更差,疲劳症状较RA组常见(88.1% vs. 50.6%, P<0.001),焦虑(10 vs. 4, P<0.01)及抑郁评分(12 vs. 6, P<0.001)更高。两组ESR、CRP、晨僵时间、肿胀关节数差异无统计学意义(P>0.05)。结论: Pollard标准在临床应用时敏感度较高,对于特异度还需要结合多方面因素综合考虑;RA-FM组患者功能状态更差,该组患者的DAS28评分可能会被高估;长时间未缓解的RA疾病活动应考虑合并FM的可能。

关键词: 类风湿关节炎, 纤维肌痛, 分类标准

Abstract:

Objective: To evaluate the sensitivity and specificity of Pollard’s classification criteria(2010) for the diagnosis of rheumatoid arthritis (RA) patients withfibromyalgia (FM) in Chinese patients, and to assess the clinical features and psychological status of RA-FM patients in a real-world observational setting. Methods: Two hundred and two patients with rheumatoid arthritis were enrolled from the outpatients in Rheumatology and Immunology Department in Peking University People’s Hospital. All the patients were evaluated whether incorporating fibromyalgia translation occured using the 1990 American College of Rheumatolgy (ACR)-FM classification criteria. Forty two RA patients were concomitant with FM, while the other one hundred and sixty RA patients without FM were set as the control group. Results: There was no significant difference in general demography between the two groups (P>0.05). In this study, the Pollard’s classification criteria (2010) for RA-FM in Chinese patients had a high sensitivity of 95.2% and relatively low specificity of 52.6%. Compared with those patients without FM, RA patients with FM (RA-FM patients) had higher Disease Activity Scale in 28 joints (DAS-28) score (5.95 vs. 4.38, P=0.011) and much more 28-tender joint counts (TJC) (16.5 vs.4.5, P<0.001).RA-FM patients had worse Health Assessment Questionnaire (HAQ) score (1.24 vs. 0.66, P<0.001) and lower SF-36 (28.63 vs. 58.22, P<0.001). Fatigue was more common in RA-FM patients (88.1% vs. 50.6%,P<0.001) and the degree of fatigue was significantly increased in RA-FM patients (fatigue VAS 5.55 vs. 3.55, P<0.001). RA-FM patients also had higher anxiety (10 vs.4, P<0.001) and depression scores (12 vs.6, P<0.001). erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), morning stiffness time and 28-swollen joint counts (SJC) showed no difference between these two groups. Conclusion: The Pollard’s classification criteria (2010) for RA-FM are feasible in Chinese rheumatoid arthritis patients. The Pollard’s classification criteria is highly sensitive in clinical application, while the relativelylow specificity indicates that various factors need to be considered in combination. RA patients with FM result in higher disease activity,worse function aland psychological status. RA patients with FM also have poorer quality of life. DAS-28 scores may be overestimated in RA patients with FM. In a RA patient thatdoes not reach remission, the possibility of fibromyalgia should be con-sidered.

Key words: Rheumatoid arthritis, Fibromyalgia, Classification

中图分类号: 

  • R593.22

表1

两组患者社会人口学特点比较"

Feature RA (n=160) RA-FM (n=42) P
Age/years, M(P25,P75) 64 (56, 71) 62.5 (56, 71.5) 0.779
Disease duration/years, M(P25,P75) 9 (4, 17.8) 11.5 (2, 21) 0.617
Gender, n(%) 0.567
Male 33 (20.6) 7 (16.7)
Female 127 (79.4) 35 (83.3)
Smoking, n(%) 144/160 (90.0) 37/42 (88.1) 0.939
Education, n(%) 0.584
Primary 26 (16.3) 9 (21.4)
Junior 47 (29.4) 11 (26.2)
Senior 41 (25.6) 14 (33.3)
Higher education 46 (28.8) 8 (19.0)
Race, n(%) 0.755
Han 152 (95.0) 41 (97.6)
Others 8 (5.0) 1 (2.4)
Marital status, n(%) 0.536
Married 155 (96.9) 42 (100.0)
Unmarried 5 (3.1) 0 (0)
Occupation, n(%) 0.792
Employed 16 (10.0) 2 (4.8)
Retired 113 (70.6) 30 (71.4)
Other 31 (19.4) 10 (23.8)

表2

两组患者临床和免疫特征比较"

Feature RA (n=160) RA-FM (n=42) P
DAS28, x -±s 4.38±1.37 5.95±1.21 0.011
TJC, M(P25, P25) 4.5 (1, 8) 16.5 (10, 24) <0.001
SJC, M(P25, P25) 1 (0, 3.75) 2 (0.75, 4) 0.470
Morning stiffness/min, M(P25, P25) 15 (0, 60) 25 (3.75, 99) 0.062
CRP/(mg/dL), M(P25, P25) 14.89 (4.10, 36.14) 27.86 (2.95, 54.68) 0.152
ESR/(mm/h), M(P25, P25) 43.50 (17.00, 70.75) 50.50 (16.75, 76.50) 0.518

表3

两组患者生活质量和功能状况比较"

Feature RA (n=160) RA-FM (n=42) P
HAQ, M(P25, P25) 0.66 (0.20, 0.90) 1.24 (0.26, 1.50) <0.001
VAS/cm, M(P25, P25) 3 (2, 5) 5 (3, 7) 0.01
SF36, M(P25, P25) 58.22 (47.26, 73.17) 28.63 (19.80, 39.97) <0.001

表4

两组患者心理和疲劳状况比较"

Feature RA (n=160) RA-FM (n=42) P-value
Anxiety 4 (1, 7) 10 (8, 12) <0.001
Depressed 6 (3, 8) 12 (10, 15) <0.001
Fatigue 81/160 37/42 <0.001
Fatigue VAS 3.55 (1.00, 4.73) 5.55 (4.61, 5.91) <0.001
[1] Clauw DJ. Fibromyalgia: A clinical review[J]. JAMA, 2014, 311(15):1547-1555.
doi: 10.1001/jama.2014.3266
[2] Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population[J]. Arthritis Rheum, 1995, 38(1):19-28.
doi: 10.1002/art.v38:1
[3] Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia[J]. J Rheumatol, 2011, 38(6):1113-1122.
[4] Wolfe F, Häuser W, Hassett AL, et al. The development of fibromyalgia: Ⅰ examination of rates and predictors in patients with rheumatoid arthritis (RA)[J]. Pain, 2011, 152(2):291-299.
doi: 10.1016/j.pain.2010.09.027
[5] Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: A population-based study in olmsted county, minnesota, utilizing the rochester epidemiology project[J]. Arthritis Care Res (Hoboken), 2013, 65(5):786-792.
doi: 10.1002/acr.21896 pmid: 23203795
[6] Joharatnam N, McWilliams DF, Wilson D, et al. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis[J]. Arthritis Res Ther, 2015, 17(1):11.
doi: 10.1186/s13075-015-0525-5
[7] Kılıçarslan A, Yurdakul FG, Bodur H. Diagnosing fibromyalgia in rheumatoid arthritis: The importance of assessing disease activity[J]. Turk J Phys Med Rehabil, 2018, 64(2):133-139.
[8] Abbasi L, Haidri FR. Fibromyalgia complicating disease management in rheumatoid arthritis[J]. J Coll Physicians Surg Pak, 2014, 24(6):424-427.
[9] Pollard LC, Kingsley GH, Choy EH, et al. Fibromyalgic rheu-matoid arthritis and disease assessment[J]. Rheumatology (Oxford), 2010, 49(5):924-928.
doi: 10.1093/rheumatology/kep458 pmid: 20100795
[10] Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia[J]. Arthritis Rheum, 1990, 33(2):160-172.
doi: 10.1002/(ISSN)1529-0131
[11] Mu R, Li C, Zhu JX, et al. National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China[J]. Int J Rheum Dis, 2013, 16(3):258-263.
doi: 10.1111/1756-185X.12055
[12] Queiroz LP. Worldwide epidemiology of fibromyalgia[J]. Curr Pain Headache Rep, 2013, 17(8):356.
doi: 10.1007/s11916-013-0356-5
[13] Wolfe F, Hauser W. Fihromyalgia diagnosis and diagnostic criteria[J]. Ann Med, 2011, 43(7):495-502.
doi: 10.3109/07853890.2011.595734
[14] Wolfe F, Clauw DJ, Fitzcharles MA, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic critera[J]. Semin Arthritis Rheum, 2016, 46(3):319-329.
doi: 10.1016/j.semarthrit.2016.08.012
[15] Kim H, Cui J, Frits M, et al. Fibromyalgia and the prediction of two-year changes in functional status in rheumatoid arthritis patients[J]. Arthritis Care Res (Hoboken), 2017, 69(12):1871-1877.
doi: 10.1002/acr.v69.12
[16] Gist AC, Guymer EK, Eades LE, et al. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia[J]. Int J Rheum Dis, 2018, 21(3):639-646.
doi: 10.1111/apl.2018.21.issue-3
[17] Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia[J]. Ann Rheum Dis, 2017, 76(2):318-328.
doi: 10.1136/annrheumdis-2016-209724 pmid: 27377815
[18] 焦娟, 贾园, 吴庆军, 等. 解读2017年欧洲抗风湿病联盟纤维肌痛治疗管理建议[J]. 中华风湿病学杂志, 2018, 22(1):68-69.
[1] 魏慧, 张警丰, 姚中强, 赵金霞. 类风湿关节炎合并慢性病贫血患者的临床特征及相关因素[J]. 北京大学学报(医学版), 2026, 58(2): 307-312.
[2] 吴滔, 林建子, 朱亚锋, 马剑达, 贾霈雯, 杨莉娟, 潘婕, 邹耀威, 杨迎, 卢烨, 戴冽. 血清蛋白质谱筛选及验证类风湿关节炎患者肌肉量减少的生物标志物[J]. 北京大学学报(医学版), 2025, 57(6): 1024-1031.
[3] 丁艳, 王丽芳, 李超然, 卢哲敏, 石连杰. 利妥昔单抗成功治疗类风湿关节炎合并IgG4相关性疾病1例[J]. 北京大学学报(医学版), 2025, 57(6): 1203-1207.
[4] 杨菊, 徐婧, 戴菊华, 石连杰. Lumican蛋白在类风湿关节炎患者血清中的表达及其与疾病和免疫活动的相关性[J]. 北京大学学报(医学版), 2025, 57(5): 911-918.
[5] 冯亮华, 洪丽荣, 陈雨佳, 蔡学明. 泛素特异性蛋白酶35对类风湿关节炎成纤维样滑膜细胞铁死亡的作用及机制[J]. 北京大学学报(医学版), 2025, 57(5): 919-925.
[6] 龙梅娟, 王怡丹, 武诗雅, 李梓豪, 李婷延, 李阳, 焦娟. 超重和肥胖对纤维肌痛综合征患者症状、整体病情及生活质量的影响[J]. 北京大学学报(医学版), 2024, 56(6): 1001-1008.
[7] 贾霈雯, 杨迎, 邹耀威, 欧阳志明, 林建子, 马剑达, 杨葵敏, 戴冽. 类风湿关节炎患者低肌肉量综合征的临床特征及其对躯体功能的影响[J]. 北京大学学报(医学版), 2024, 56(6): 1009-1016.
[8] 马豆豆, 卢哲敏, 郭倩, 朱莎, 古今, 丁艳, 石连杰. 小剂量利妥昔单抗成功治疗类风湿关节炎合并重症肌无力1例[J]. 北京大学学报(医学版), 2024, 56(6): 1110-1114.
[9] 闫蕊, 柯丹, 张妍, 李丽, 苏焕然, 陈伟, 孙明霞, 刘晓敏, 罗靓. 血清趋化因子CXCL-10和涎液化糖链抗原6水平在类风湿关节炎合并肺间质病变患者中的诊断和病情评估价值[J]. 北京大学学报(医学版), 2024, 56(6): 956-962.
[10] 赵亮, 史成龙, 马柯, 赵静, 王潇, 邢晓燕, 莫万星, 练益瑞, 高超, 李玉慧. 抗合成酶综合征重叠类风湿关节炎患者的免疫学特征[J]. 北京大学学报(医学版), 2024, 56(6): 972-979.
[11] 韩艺钧, 陈小莉, 李常虹, 赵金霞. 甲氨蝶呤在类风湿关节炎患者中的应用现状[J]. 北京大学学报(医学版), 2024, 56(6): 994-1000.
[12] 刘东武, 陈杰, 高明利, 于静. 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024, 56(5): 928-931.
[13] 黄会娜,赵静,赵祥格,白自然,李霞,王冠. 乳酸对类风湿关节炎患者外周血CD4+T细胞亚群的调控作用[J]. 北京大学学报(医学版), 2024, 56(3): 519-525.
[14] 汤晓菲,李永红,丁秋玲,孙卓,张阳,王育梅,田美伊,刘坚. 类风湿关节炎患者下肢深静脉血栓发病率及危险因素[J]. 北京大学学报(医学版), 2024, 56(2): 279-283.
[15] 邹雪,白小娟,张丽卿. 艾拉莫德联合托法替布治疗难治性中重度类风湿关节炎的疗效[J]. 北京大学学报(医学版), 2023, 55(6): 1013-1021.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!